Nuzenio

Rlmd

Rlmd news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 24 latest news signals 9 publisher sources 100/100 entity strength

Latest news

Q2 2026 Relmada Therapeutics Inc Earnings Call Transcript - GuruFocusGuruFocus · Sat, 08 Aug 2026 04:58:05 GMT Piper Sandler Maintains Relmada Therapeutics(RLMD.US) With Buy Rating, Maintains Target Price $12 - MoomooMoomoo · Sat, 08 Aug 2026 00:10:19 GMT Relmada Therapeutics Q2 Earnings Call Highlights - Yahoo FinanceYahoo Finance · Fri, 07 Aug 2026 11:03:56 GMT Relmada Therapeutics (RLMD) Boosts Cash Reserves Ahead of Key IN - GuruFocusGuruFocus · Fri, 07 Aug 2026 10:44:11 GMT Relmada Therapeutics Inc (RLMD) (Q2 2026) Earnings Call Highlights: Strong Phase 2 Data and FDA ... - Yahoo! Finance CanadaYahoo! Finance Canada · Fri, 07 Aug 2026 05:09:29 GMT RLMD: Strong cash position and robust NDV-01 phase II results set stage for late-stage trials in 2026 - TradingViewTradingView · Thu, 06 Aug 2026 21:59:56 GMT Relmada Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary - TradingViewTradingView · Thu, 06 Aug 2026 21:49:35 GMT Relmada Therapeutics (Nasdaq: RLMD) details Q2 2026 loss and NDV-01 Phase 3 path - Stock TitanStock Titan · Thu, 06 Aug 2026 20:41:35 GMT

Timeline

Sat, 08 Aug 2026 04:58:05 GMTQ2 2026 Relmada Therapeutics Inc Earnings Call Transcript - GuruFocus

Sat, 08 Aug 2026 00:10:19 GMTPiper Sandler Maintains Relmada Therapeutics(RLMD.US) With Buy Rating, Maintains Target Price $12 - Moomoo

Fri, 07 Aug 2026 11:03:56 GMTRelmada Therapeutics Q2 Earnings Call Highlights - Yahoo Finance

Fri, 07 Aug 2026 10:44:11 GMTRelmada Therapeutics (RLMD) Boosts Cash Reserves Ahead of Key IN - GuruFocus

Fri, 07 Aug 2026 05:09:29 GMTRelmada Therapeutics Inc (RLMD) (Q2 2026) Earnings Call Highlights: Strong Phase 2 Data and FDA ... - Yahoo! Finance Canada

Thu, 06 Aug 2026 21:59:56 GMTRLMD: Strong cash position and robust NDV-01 phase II results set stage for late-stage trials in 2026 - TradingView

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.

Connected entities

RLMD Feb14 live mentions Yahoo Finance Singapore6 live mentions Relmada Therapeutics5 live mentions Yahoo Finance Yahoo5 live mentions Relmada Therapeutics Inc4 live mentions Earnings Call Highlights4 live mentions NDV4 live mentions TradingView RLMD4 live mentions EPS4 live mentions Yahoo Finance4 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Rlmd.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

9 distinct publisher/source names are currently connected to this entity page.